Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Aug 28, 2026

GLPG — Lakefront Biotherapeutics NV Dilution Risk Tracker

Track GLPG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GLPG — Get alerts when the score changes →

As of August 28, 2026, Lakefront Biotherapeutics NV (GLPG) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Lakefront Biotherapeutics NV has a market capitalization of $1.86B, 65.90M shares outstanding, 92 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for GLPG.
🔔 Track GLPG — Get forecast alerts →

Market Data

Market Cap$1.86B
Shares Outstanding65.90M
Float44.52M
Cash$3.48B
Debt$7.50M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 2.6% shares (2026Q1 vs prior)
92 institutional holders · 32.56M shares
#1 GILEAD SCIENCES, INC. 16.71M shares
#2 TANG CAPITAL MANAGEMENT LLC 3.79M shares
#3 Madison Avenue Partners, LP 2.47M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track GLPG Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GLPG — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GLPG
GLPG FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.